Study of association between hypertensive disorders of pregnancy and the human coagulation factor XI gene

被引:7
作者
Sato, I
Nakayama, T
Maruyama, A
Furuya, K
Sato, N
Mizutani, Y
Yamamoto, T
机构
[1] Nihon Univ, Sch Med, Div Mol Diagnost, Adv Med Res Ctr,Itabashi Ku, Tokyo 1738610, Japan
[2] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1738610, Japan
[3] Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo 1738610, Japan
关键词
hypertensive disorders of pregnancy; preeclampsia; coagulation; factor XI; polymorphism; genetic;
D O I
10.1080/10641950500543863
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Hypertensive disorders of pregnancy (HDP) are among the most common and serious complications of pregnancy. Persuasive evidence implicaties genetic factors in the genesis of HDP. The aim of the present study was to assess the association between single-nucleotide polymorphisms (SNPs) in the human coagulation factor XI (F11) gene and HDP, by conducting a haplotype-based case-control study. Methods: We chose 3 SNPs (rs925453, rs925451, and rs12500151) in the human F11 gene as genetic markers. We then conducted an association study with 77 HDP patients and 154 age-matched non-HDP subjects. Results: The frequency of rs925453 genotypes significantly differed between the two groups. The frequency of the T-G-G haplotype was significantly higher in the HDP group than in the non-HDP group (p = 0.0002). Conclusions: The T allele of rs925453 and the T-G-G haplotype appear to be useful genetic markers of HDP.
引用
收藏
页码:21 / 31
页数:11
相关论文
共 35 条
  • [1] ORGANIZATION OF THE GENE FOR HUMAN FACTOR-XI
    ASAKAI, R
    DAVIE, EW
    CHUNG, DW
    [J]. BIOCHEMISTRY, 1987, 26 (23) : 7221 - 7228
  • [2] FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL
    ASAKAI, R
    CHUNG, DW
    DAVIE, EW
    SELIGSOHN, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) : 153 - 158
  • [3] DENTAL SURGERY IN PATIENTS WITH SEVERE FACTOR-XI DEFICIENCY WITHOUT PLASMA REPLACEMENT
    BERLINER, S
    HOROWITZ, I
    MARTINOWITZ, U
    BRENNER, B
    SELIGSOHN, U
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 465 - 468
  • [4] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [5] Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24
  • [6] Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia
    Chen, G
    Wilson, R
    Wang, SH
    Zheng, HZ
    Walker, JJ
    McKillop, JH
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (01) : 154 - 159
  • [7] SERIAL STUDY OF COAGULATION-FACTORS XII, XI AND X IN PLASMA IN NORMAL-PREGNANCY AND IN PREGNANCY COMPLICATED BY PRE-ECLAMPSIA
    CONDIE, RG
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1976, 83 (08): : 636 - 639
  • [8] Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
    DizonTomson, DS
    Meline, L
    Nelson, LM
    Warner, M
    Ward, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (02) : 402 - 405
  • [9] The factor V Leiden mutation may predispose women to severe preeclampsia
    DizonTownson, DS
    Nelson, LM
    Easton, K
    Ward, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (04) : 902 - 905
  • [10] EATON DL, 1991, J BIOL CHEM, V266, P21833